Results 211 to 220 of about 90,268 (296)

Clathrate hydrate crystallization

open access: yesThe Canadian Journal of Chemical Engineering, Volume 104, Issue 11, Page 5931-5953, November 2026.
Abstract Clathrate hydrate crystallization has been an area of interest to chemical engineers from the point of view of crystal structure, thermophysical properties, phase equilibria, kinetics, industrial applications, and environmental (climate change) implications.
Peter Englezos
wiley   +1 more source

Proteomic signatures of equine dental tooth tissues in ageing and disease

open access: yesEquine Veterinary Journal, Volume 58, Issue 6, Page 1552-1569, November 2026.
Abstract Background Ageing and dental disease in horses lead to structural and functional deterioration of dental tissues, yet their molecular signatures remain poorly characterised. Understanding how these processes alter the protein composition of enamel, dentin, cementum and pulp is essential for improving equine oral health and identifying ...
Anders Jensen   +8 more
wiley   +1 more source

Nash, AFP

open access: yes, 2016
Nash, AFP
core  

Leiomyosarcoma of the Renal Vein That Enlarged Laterally While Preserving the Structure of the Renal Vein Lumen

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Primary renal vein leiomyosarcoma is an extremely rare disease and the tumor often infiltrates the vessel wall. We report a case of primary renal vein leiomyosarcoma that enlarged while preserving the structure of the renal vein lumen.
Naoki Tashiro   +9 more
wiley   +1 more source

Rapidly Progressive Metastatic Sertoli Cell Tumor Associated With an Adenomatous Polyposis Coli Mutation: A Case Report and Literature Review

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Sertoli cell tumors are rare testicular sex cord‐stromal tumors, and clinically malignant behavior is uncommon. We report a rapidly progressive metastatic Sertoli cell tumor associated with an APC mutation. Case Presentation A 27‐year‐old man with familial adenomatous polyposis (FAP) presented with painless right scrotal ...
Kotaro Obayashi   +9 more
wiley   +1 more source

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. [PDF]

open access: yesJHEP Rep
Suda G   +28 more
europepmc   +1 more source

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background & Aims The management of comorbidities has become increasingly relevant in unresectable hepatocellular carcinoma (uHCC) as immunotherapy prolongs survival. Atezolizumab plus bevacizumab (AB) is a standard first‐line option, but bevacizumab carries a risk of cardiovascular toxicities.
Bernardo Stefanini   +55 more
wiley   +1 more source

Home - About - Disclaimer - Privacy